• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪酸结合蛋白 4 水平升高受高血压家族史影响,并导致血压升高。

Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation.

机构信息

Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan.

出版信息

Am J Hypertens. 2012 Oct;25(10):1124-30. doi: 10.1038/ajh.2012.88. Epub 2012 Jun 21.

DOI:10.1038/ajh.2012.88
PMID:22717543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3449332/
Abstract

BACKGROUND

Fatty acid-binding protein 4 (FABP4/A-FABP/aP2), a lipid chaperone, is expressed in both adipocytes and macrophages. Recent studies have shown secretion of FABP4 from adipocytes and association of elevated serum FABP4 level with obesity, insulin resistance, and atherosclerosis. However, little is known about the role of FABP4 in essential hypertension.

METHODS

We first examined serum FABP4 concentrations in 18 normotensives (NT) and 30 nontreated essential hypertensives (EHT). The EHT were divided into 18 insulin-sensitive EHT (EHT-S) and 12 insulin-resistant EHT (EHT-R) based on their insulin-sensitivity index, the M value, determined by the hyperinsulinemic-euglycemic clamp technique. In the second study, we determined FABP4 levels in 30 young NT men with or without a family history of hypertension (FH(+) and FH(-), respectively; n = 15 each).

RESULTS

Serum FABP4 level was significantly higher in the EHT-R than in the NT, whereas elevation of FABP4 level in the EHT-S was not statistically significant. FABP4 level was positively correlated with age, body mass index (BMI), blood pressure, and triglycerides and negatively correlated with the M value. FABP4 level was an independent predictor of mean arterial pressure after adjustment of age, gender, and adiposity. The FH(+) group had a significantly lower level of M value and higher level of FABP4 than did the FH(-) group, and FABP4 concentration was an independent determinant of the M value.

CONCLUSIONS

FABP4 contributes to blood pressure elevation and atherogenic metabolic phenotype in hypertensives, and the elevation of FABP4 is predisposed by a family history of hypertension.

摘要

背景

脂肪酸结合蛋白 4(FABP4/A-FABP/aP2)是一种脂质伴侣蛋白,在脂肪细胞和巨噬细胞中均有表达。最近的研究表明,脂肪细胞分泌 FABP4,血清 FABP4 水平升高与肥胖、胰岛素抵抗和动脉粥样硬化有关。然而,关于 FABP4 在原发性高血压中的作用知之甚少。

方法

我们首先检测了 18 名正常血压者(NT)和 30 名未经治疗的原发性高血压患者(EHT)的血清 FABP4 浓度。根据胰岛素敏感指数 M 值,将 EHT 分为 18 名胰岛素敏感 EHT(EHT-S)和 12 名胰岛素抵抗 EHT(EHT-R)。在第二项研究中,我们检测了 30 名年轻 NT 男性的 FABP4 水平,这些男性中分别有(FH(+))和无(FH(-))家族高血压史,每组 15 人。

结果

EHT-R 组血清 FABP4 水平明显高于 NT 组,而 EHT-S 组 FABP4 水平升高无统计学意义。FABP4 水平与年龄、体重指数(BMI)、血压和甘油三酯呈正相关,与 M 值呈负相关。调整年龄、性别和肥胖后,FABP4 水平是平均动脉压的独立预测因子。FH(+)组的 M 值明显低于 FH(-)组,FABP4 水平也明显高于 FH(-)组,且 FABP4 浓度是 M 值的独立决定因素。

结论

FABP4 导致高血压患者血压升高和动脉粥样硬化代谢表型,家族高血压史使 FABP4 升高的倾向性增加。

相似文献

1
Elevation of fatty acid-binding protein 4 is predisposed by family history of hypertension and contributes to blood pressure elevation.脂肪酸结合蛋白 4 水平升高受高血压家族史影响,并导致血压升高。
Am J Hypertens. 2012 Oct;25(10):1124-30. doi: 10.1038/ajh.2012.88. Epub 2012 Jun 21.
2
Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension.血管紧张素II受体阻滞剂可降低高血压患者血清脂肪酸结合蛋白4的浓度。
Hypertens Res. 2015 Apr;38(4):252-9. doi: 10.1038/hr.2015.2. Epub 2015 Feb 12.
3
Association of insulin resistance and hyperinsulinemia with disturbed lipid metabolism in patients with essential hypertension.原发性高血压患者胰岛素抵抗和高胰岛素血症与脂质代谢紊乱的关联。
Hypertens Res. 1998 Mar;21(1):57-62. doi: 10.1291/hypres.21.57.
4
Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension.阻断肾素-血管紧张素系统可增加原发性高血压患者的脂联素浓度。
Hypertension. 2003 Jul;42(1):76-81. doi: 10.1161/01.HYP.0000078490.59735.6E. Epub 2003 Jun 9.
5
Role of adiponectin in insulin-resistant hypertension and atherosclerosis.脂联素在胰岛素抵抗性高血压和动脉粥样硬化中的作用。
Hypertens Res. 2003 Sep;26(9):705-10. doi: 10.1291/hypres.26.705.
6
Circulating resistin levels in essential hypertension.
Clin Endocrinol (Oxf). 2003 Oct;59(4):507-10. doi: 10.1046/j.1365-2265.2003.01879.x.
7
Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.血清脂肪酸结合蛋白 4 是终末期肾病患者心血管事件的预测因子。
PLoS One. 2011;6(11):e27356. doi: 10.1371/journal.pone.0027356. Epub 2011 Nov 10.
8
Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population.在普通人群中,循环脂肪酸结合蛋白4水平升高与左心室舒张功能障碍独立相关。
Cardiovasc Diabetol. 2014 Aug 21;13:126. doi: 10.1186/s12933-014-0126-7.
9
Lipocalin-2, A-FABP and inflammatory markers in relation to flow-mediated vasodilatation in patients with essential hypertension.脂联素-2、A-FABP 与原发性高血压患者血流介导的血管舒张功能的关系及炎症标志物。
Clin Exp Hypertens. 2014;36(7):478-83. doi: 10.3109/10641963.2013.863320. Epub 2014 Feb 3.
10
Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals.循环脂肪酸结合蛋白 4 水平是中老年人群代谢功能障碍相关脂肪性肝病的独立预测因子。
J Diabetes Investig. 2022 May;13(5):878-888. doi: 10.1111/jdi.13735. Epub 2022 Jan 3.

引用本文的文献

1
Elevated urinary fatty acid-binding protein 4 level predicts future renal dysfunction and poor prognosis in Japanese patients with diabetes: a longitudinal cohort study.尿脂肪酸结合蛋白4水平升高可预测日本糖尿病患者未来的肾功能不全及不良预后:一项纵向队列研究
Clin Kidney J. 2025 Mar 12;18(4):sfaf056. doi: 10.1093/ckj/sfaf056. eCollection 2025 Apr.
2
Elevated Circulating Adipocyte-Fatty Acid Binding Protein Levels Predict Incident Ischemic Cardiovascular Events in a Longitudinal and Prospective AMI Aging Study.在一项纵向前瞻性急性心肌梗死衰老研究中,循环中脂肪细胞脂肪酸结合蛋白水平升高可预测缺血性心血管事件的发生。
J Inflamm Res. 2025 Feb 4;18:1589-1608. doi: 10.2147/JIR.S494049. eCollection 2025.
3

本文引用的文献

1
Lipid chaperones and metabolic inflammation.脂质伴侣与代谢性炎症。
Int J Inflam. 2011;2011:642612. doi: 10.4061/2011/642612. Epub 2011 Oct 30.
2
Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.血清脂肪酸结合蛋白 4 是终末期肾病患者心血管事件的预测因子。
PLoS One. 2011;6(11):e27356. doi: 10.1371/journal.pone.0027356. Epub 2011 Nov 10.
3
Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes.
Urinary fatty acid-binding protein 4 is a promising biomarker for glomerular damage in patients with diabetes mellitus.
尿脂肪酸结合蛋白4是糖尿病患者肾小球损伤的一种有前景的生物标志物。
J Diabetes Investig. 2025 Apr;16(4):670-679. doi: 10.1111/jdi.14388. Epub 2024 Dec 26.
4
Fatty Acid-Binding Protein 4-Mediated Regulation Is Pivotally Involved in Retinal Pathophysiology: A Review.脂肪酸结合蛋白 4 介导的调节在视网膜病理生理学中起着关键作用:综述。
Int J Mol Sci. 2024 Jul 14;25(14):7717. doi: 10.3390/ijms25147717.
5
High Fatty Acid-Binding Protein 4 Expression Associated with Favorable Clinical Characteristics and Prognosis in Papillary Thyroid Carcinoma.高脂结合蛋白 4 的表达与甲状腺乳头状癌的良好临床特征和预后相关。
Endocr Pathol. 2024 Sep;35(3):245-255. doi: 10.1007/s12022-024-09815-2. Epub 2024 Jun 17.
6
Investigating the Role of FABP4 in Diabetes and Obesity and the Influence of Age and Ethnicity: A Comprehensive Analysis of a Cohort from the KEDP-Study.探讨 FABP4 在糖尿病和肥胖中的作用以及年龄和种族的影响:来自 KEDP 研究队列的综合分析。
Int J Mol Sci. 2024 Apr 23;25(9):4578. doi: 10.3390/ijms25094578.
7
Metabolic dysfunction-associated fatty liver disease is associated with an increase in systolic blood pressure over time: linear mixed-effects model analyses.代谢相关脂肪性肝病与收缩压随时间的升高相关:线性混合效应模型分析。
Hypertens Res. 2023 May;46(5):1110-1121. doi: 10.1038/s41440-023-01179-0. Epub 2023 Jan 30.
8
Fatty Acid-Binding Proteins 4 and 5 Are Involved in the Pathogenesis of Retinal Vascular Diseases in Different Manners.脂肪酸结合蛋白4和5以不同方式参与视网膜血管疾病的发病机制。
Life (Basel). 2022 Mar 23;12(4):467. doi: 10.3390/life12040467.
9
Association between Serum Adipocyte Fatty Acid Binding Protein Level and Endothelial Dysfunction in Chronic Hemodialysis Patients.慢性血液透析患者血清脂肪细胞脂肪酸结合蛋白水平与内皮功能障碍的关系
Life (Basel). 2022 Feb 20;12(2):316. doi: 10.3390/life12020316.
10
Circulating level of fatty acid-binding protein 4 is an independent predictor of metabolic dysfunction-associated fatty liver disease in middle-aged and elderly individuals.循环脂肪酸结合蛋白 4 水平是中老年人群代谢功能障碍相关脂肪性肝病的独立预测因子。
J Diabetes Investig. 2022 May;13(5):878-888. doi: 10.1111/jdi.13735. Epub 2022 Jan 3.
Mal1 基因敲除的巨噬细胞通过激活过氧化物酶体增殖物激活受体 γ 调控基因抑制低密度脂蛋白受体缺陷型小鼠动脉粥样硬化的形成。
Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1283-90. doi: 10.1161/ATVBAHA.111.225839. Epub 2011 Apr 7.
4
Chronic administration of BMS309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells.慢性给予 BMS309403 可改善载脂蛋白 E 缺陷小鼠和培养的人内皮细胞的内皮功能。
Br J Pharmacol. 2011 Apr;162(7):1564-76. doi: 10.1111/j.1476-5381.2010.01158.x.
5
Olmesartan reduces arterial stiffness and serum adipocyte fatty acid-binding protein in hypertensive patients.奥美沙坦可降低高血压患者的动脉僵硬度和血清脂肪细胞脂肪酸结合蛋白水平。
Heart Vessels. 2011 Jul;26(4):408-13. doi: 10.1007/s00380-010-0060-x. Epub 2010 Nov 10.
6
Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes.脂肪酸结合蛋白 4 与 2 型糖尿病患者的内皮功能障碍有关。
Atherosclerosis. 2010 Nov;213(1):329-31. doi: 10.1016/j.atherosclerosis.2010.07.026. Epub 2010 Jul 27.
7
Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells.脂肪酸结合蛋白4是血管内皮生长因子的一个靶点,也是内皮细胞中细胞增殖的一个调节因子。
FASEB J. 2009 Nov;23(11):3865-73. doi: 10.1096/fj.09-134882. Epub 2009 Jul 22.
8
Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice.脂肪细胞/巨噬细胞脂肪酸结合蛋白通过在小鼠巨噬细胞和脂肪细胞中的作用导致代谢恶化。
J Clin Invest. 2008 Jul;118(7):2640-50. doi: 10.1172/JCI34750.
9
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets.脂肪酸结合蛋白:在代谢性疾病中的作用及作为药物靶点的潜力
Nat Rev Drug Discov. 2008 Jun;7(6):489-503. doi: 10.1038/nrd2589.
10
Blood pressure change and risk of hypertension associated with parental hypertension: the Johns Hopkins Precursors Study.与父母高血压相关的血压变化及高血压风险:约翰·霍普金斯前驱研究
Arch Intern Med. 2008 Mar 24;168(6):643-8. doi: 10.1001/archinte.168.6.643.